Compare KALV & CURV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KALV | CURV |
|---|---|---|
| Founded | N/A | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Clothing/Shoe/Accessory Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 551.2M | 185.4M |
| IPO Year | N/A | 2021 |
| Metric | KALV | CURV |
|---|---|---|
| Price | $15.51 | $1.08 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 6 |
| Target Price | ★ $27.17 | $1.59 |
| AVG Volume (30 Days) | ★ 1.1M | 488.5K |
| Earning Date | 11-10-2025 | 12-03-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $1,426,000.00 | ★ $1,039,486,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $204.16 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $7.30 | $0.94 |
| 52 Week High | $17.30 | $7.19 |
| Indicator | KALV | CURV |
|---|---|---|
| Relative Strength Index (RSI) | 52.76 | 46.92 |
| Support Level | $14.83 | $0.96 |
| Resistance Level | $16.30 | $1.08 |
| Average True Range (ATR) | 0.89 | 0.09 |
| MACD | -0.15 | 0.01 |
| Stochastic Oscillator | 30.00 | 53.46 |
KalVista Pharmaceuticals Inc is a pharmaceutical company developing and delivering oral therapies for individuals affected by rare diseases with unmet needs. The company applies its knowledge in the kallikrein-kinin system (KKS) and oral drug discovery to develop small-molecule protease inhibitor medicines to address the needs of patients with diseases driven by plasma kallikrein and Factor XIIa. Its FDA-approved product EKTERLY (sebetralstat) is a novel, orally delivered, small-molecule plasma kallikrein inhibitor for the treatment of acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged twelve years and older.
Torrid Holdings Inc is a direct-to-consumer brand of apparel, intimates, and accessories in North America. The company is focused on fit and offers high-quality products across a broad assortment that includes tops, bottoms, denim, dresses, intimates, activewear, footwear, and accessories. The company has one reportable segment, which includes the operation of the e-commerce platform and stores. The company generates revenue from the sale of apparel, intimates, and accessories through its e-commerce platform and its store locations.